Tracey McCain
Compliance Officer bei BLUEPRINT MEDICINES CORPORATION
Vermögen: 6 Mio $ am 31.03.2024
Profil
Tracey L.
McCain is an Independent Director at Kiniksa Pharmaceuticals Ltd.
and Secretary, Chief Legal & Compliance Officer at Blueprint Medicines Corp.
She was previously a General Counsel at Genzyme Corp.
and a Senior Vice President & Head-Legal at Genzyme Therapeutics Ltd.
She also worked as an Associate at Palmer & Dodge LLP.
McCain received her undergraduate degree from the University of Pennsylvania and her graduate degree from Columbia Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.03.2024 | 60 498 ( 0,10% ) | 6 Mio $ | 31.03.2024 | |
| 29.06.2023 | 5 000 ( 0,01% ) | 98 650 $ | 31.03.2024 |
Aktive Positionen von Tracey McCain
| Unternehmen | Position | Beginn |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Compliance Officer | 06.09.2016 |
| KINIKSA PHARMACEUTICALS, LTD. | Director/Board Member | 01.02.2018 |
Ehemalige bekannte Positionen von Tracey McCain
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOGEN, INC. | Director/Board Member | 12.02.2024 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | General Counsel | 02.09.2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01.09.2016 |
| Palmer & Dodge LLP | Corporate Officer/Principal | - |
Ausbildung von Tracey McCain
| University of Pennsylvania | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
